Impact Therapeutics Patents – Insights & Stats (Updated 2024)

Impact Therapeutics has a total of 222 patents globally, out of which 96 have been granted. Of these 222 patents, more than 74% patents are active. China is where Impact Therapeutics has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems to be the main focused R&D centre and also is the origin country of Impact Therapeutics.

Impact Therapeutics was founded in 2009. Impact Therapeutics focuses on developing innovative treatments for cancer and other severe diseases. The company is committed to discovering and developing targeted anti-cancer therapeutics utilizing synthetic lethality, offering patients cutting-edge targeted anti-cancer drugs.

Do read about some of the most popular patents of Impact Therapeutics which have been covered by us in this article and also you can find Impact Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Impact Therapeutics patent portfolio.

How many patents does Impact Therapeutics have?

Impact Therapeutics has a total of 222 patents globally. These patents belong to 37 unique patent families. Out of 222 patents, 166 patents are active.

How Many Patents did Impact Therapeutics File Every Year?

Impact Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantImpact Therapeutics Applications FiledImpact Therapeutics Patents Granted
202438
202376
20223714
20212012
20203524
2019414
2018153
2017292
2016137
20154
201411

How many Impact Therapeutics patents are Alive/Dead?

Worldwide Patents

Impact Therapeutics Patent Filing Trend

How Many Patents did Impact Therapeutics File in Different Countries?

Impact Therapeutics Worldwide Patent Filing

Countries in which Impact Therapeutics Filed Patents

CountryPatent
China32
United States of America27
Europe (EPO)17
Canada13
Australia11
Japan11
Germany8
Austria6
Spain5
Denmark4
Singapore4
Italy4
Brazil3
South Africa3
Mexico3
Hong Kong (S.A.R.)3
Hungary3
New Zealand3
Israel2
Slovakia2
Serbia2
Taiwan2
Slovenia2
Cyprus2
Croatia2
Portugal2
Norway2
Poland2
Estonia1
Turkey1
Korea (South)1

Where are Research Centers of Impact Therapeutics Patents Located?

R&D Centres of Impact Therapeutics

10 Best Impact Therapeutics Patents

WO2012065546A1 is the most popular patent in the Impact Therapeutics portfolio. It has received 80 citations so far from companies like Incyte, Praxis Precision Medicines.

Below is the list of 10 most cited patents of Impact Therapeutics:

Publication NumberCitation Count
WO2012065546A180
WO2012065297A176
WO2012130166A141
WO2014012511A137
WO2018090939A133
WO2013013614A130
WO2019011228A114
WO2013064083A113
CN103570625A11
WO2018082587A111

What are Impact Therapeutics key innovation segments?

What Technologies are Covered by Impact Therapeutics?

The chart below distributes patents filed by Impact Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Impact Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Impact Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Impact Therapeutics?

Related Articles

Tyroler Patents – Insights & Stats (Updated 2024)

Tyroler has a total of 55 patents globally, out of which 38 have been granted. Of these 55 patents, more than 85% patents are active. United States of America is where Tyroler has filed the maximum number of patents, followed by China and Israel. Parallelly, Israel seems to be the

Read More »

Plasmatica Patents – Insights & Stats (Updated 2024)

Plasmatica has a total of 50 patents globally, out of which 30 have been granted. Of these 50 patents, more than 94% patents are active. United States of America is where Plasmatica has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, Israel seems to be

Read More »

Breaking Barriers: Women Inventors driving innovation at Walmart

Women make up a significant portion of Walmart’s customer base, accounting for approximately 60% of shoppers, compared to 40% men (source). However, their contributions extend far beyond the consumer role—they are also shaping innovations within the company. Gender Diversity and Corporate Innovation The conversation around Diversity, Equity, and Inclusion (DEI)

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.